Cargando…
Cetuximab-induced aseptic meningitis: case report and review of a rare adverse event
BACKGROUND: Cetuximab is a commonly used antibody agent in the treatment of colorectal or head and neck cancer. Although it is generally well tolerated in most patients, cetuximab has been associated with some rare but serious adverse events. Aseptic meningitis is one such distinctly uncommon advers...
Autores principales: | Maritaz, Christophe, Metz, Carole, Baba-Hamed, Nabil, Jardin-Szucs, Méryam, Deplanque, Gaël |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932661/ https://www.ncbi.nlm.nih.gov/pubmed/27378078 http://dx.doi.org/10.1186/s12885-016-2434-7 |
Ejemplares similares
-
Aseptic Meningitis as an Immune-Related Adverse Event after Pembrolizumab
por: Lima, Gian, et al.
Publicado: (2019) -
Cetuximab-Induced Aseptic Meningitis in a Patient with Colorectal Cancer: A Case Report and Review of Literature
por: Jäger, Jakob, et al.
Publicado: (2022) -
Pembrolizumab-induced aseptic meningitis in a patient with non-small cell lung cancer: A case report and literature review of aseptic meningitis as an immune-related adverse event
por: Inui, Genki, et al.
Publicado: (2022) -
Acute Aseptic Meningitis
por: Gour, K. N.
Publicado: (1943) -
Tozinameran: Aseptic meningitis: case report
Publicado: (2022)